Rating Card

premiumPremium content

Unlock Expert's Rating and Top Picks Portfolio

Curated by Michael O'Reilly since 2020
1550+ opinions with 4.81 rating (one of the best performing expert)

Latest Top Picks

Stock Opinions by The Panic-Proof Portfolio (Stockchase Research)

Most recent Opinions go here

Be up to date, don’t miss your chance.

TOP PICK
Stockchase Research Editor: Michael O'Reilly

This Vanguard ETF focuses on US equities that demonstrate growing dividends over time -- a good inflation hedge along with growth potential.  What makes it particularly interesting is its lower volatility despite a 13% average annual growth since inception over 10 years ago.  It also ranked in the top10% of an informal evaluation for minimizing losses during the market downturns in 2022 and 2018.  We recommend setting a stop-loss at $83, looking to achieve $111 -- upside potential of 18%.  Yield 1.1% 

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

This iShares ETF focuses on equities outside of North America and also excludes China - providing excellent market diversification.  It targets companies that demonstrate lower volatility over time along with growth potential.  What makes it particularly interesting is its lower volatility despite a 9% average annual growth since inception over 10 years ago.  It also ranked in the top10% of an informal evaluation for minimizing losses during the market downturns in 2022 and 2018.  We recommend setting a stop-loss at $41.00, looking to achieve $52.50 -- upside potential of 18%.  Yield 1.8% 

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

This iShares ETF focuses on global equities (60% North American) - providing excellent market diversification.  It targets companies that demonstrate lower volatility over time along with growth potential.  What makes it particularly interesting is its lower volatility despite a 10% average annual growth since inception over 10 years ago.  It also ranked in the top10% of an informal evaluation for minimizing losses during the market downturns in 2022 and 2018.  We recommend setting a stop-loss at $50, looking to achieve $68 -- upside potential of 18%.  Yield 2.3% 

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 01/25, Up 32.4%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with KNT has reached its target at $16.  To remain disciplined, we recommend covering half the position at this time and trailing up the stop (from $9.50) to $13.50.  

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate Indonesia's largest telecom with over 160 million customers as a TOP PICK.  Recently released earnings showed a 10% growth in personal account revenues along with a 14% increase in data consumption.  This allowed cash reserves to continue to grow, despite aggressively retiring debt and buying back shares.  It trades at 12x earnings, 2x book and supports a ROE of 16%.  We recommend trailing up the stop (from $12.00) to $15.00, looking to achieve $20.50 -- upside potential of 17%.  Yield 6.5%

(Analysts’ price target is $20.12)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate this pharma producer as a TOP PICK.  The company just announced a $9.5 billion acquisition that will help foster a pipeline of treatments for inflammation and other disorders that is already paying out growing cash flow.  It trades at 21x earnings and 1.5x book.  Dividend growth is expected over 40% this year, backed by a payout ratio under two-thirds of cash flow.  Cash reserves are prudently being used to retire debt and buy back shares.  We continue to recommend a stop at $47, looking to achieve $65 -- upside potential of 30%.  Yield 4.5%  

(Analysts’ price target is $65.16)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate this US home builder as a TOP PICK.  Recently reported earnings showed revenue growth of 11% with margins of 25%.  It trades at 7x earnings, under book value and supports a 16% ROE.  It is prudently using some cash reserves to buyback shares and retire debt.  We continue to recommend a stop at $52.00, looking to achieve $73.50 -- upside potential of 26%.  Yield 0%

(Analysts’ price target is $73.38)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jan 21/25, Down 3.9%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with DLR has triggered its stop at $14.  To remain disciplined, we recommend covering the position at this time.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 27/25, Down 24.6%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with CAL has triggered its stop at $13.50.  To remain disciplined, we recommend covering the position at this time.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate VIST as a TOP PICK.  The Mexican based energy producer recently announced it has purchased Petronas' 100% interests in Argentina where the companies were partnered.  This will add capital efficiencies and further enhance cash flow in the area they project.  It trades at 10x earnings, 3 times book and supports a robust 33% ROE.  We recommend trailing up the stop (from $35) to $39, looking to achieve $69 -- upside potential of 33%.  Yield 0%

(Analysts’ price target is $69.48)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate this electric transformer manufacturer, involved in data centre and cloud projects, as a TOP PICK.  Recently reported earnings showed a 5% increase in year on year sales and a 17% increase in backlog of orders, which is great timing considering their new production factory is expected to open sooner than expected.  It trades at 14x earnings, 3x book and supports a robust 31% ROE.  We recommend trailing up the stop (from $70) to $80, looking to achieve $131 -- upside potential of 28%.  Yield 1.1%

(Analysts’ price target is $148.25)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate UPWK as a TOP PICK.  EPS growth over the past three years has been impressive, while the company supports a robust 49% ROE.  It trades at 13x earnings and 3x book.  Cash reserves continue to grow as shares are bought back.  We continue to recommend a stop at $13, looking to achieve $19 -- upside potential of 22%.  Yield 0%

(Analysts’ price target is $19.10)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jan 16/25, Up 21.3%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with GSK has achieved its target at $41.  To remain disciplined, we recommend covering half the position at this time and maintaining the stop at $32.  

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Apr 29/25, Up 15.6%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with SES is progressing well.  To remain disciplined, we recommend trailing up the stop (from $9) to $12 at this time.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Apr 29/25, Up 15.6%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with SES is progressing well.  To remain disciplined, we recommend trailing up the stop (from $9) to $12 at this time.

Showing 1 to 15 of 3,141 entries